Search research articles
Contact Us
Filters
Showing results (311-320 of 402) with videos related to
Page
of 41
Sort By:
Gynecologic Oncology
|
January 11, 2011
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma
John P Diaz, Mary L Gemignani, Neeta Pandit-Taskar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 9, 2013
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications
Samith Sandadi, Edward J Tanner, Fady Khoury-Collado, et al.
Gynecologic Oncology
|
March 4, 2014
Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies
Elizabeth L Jewell, Juan Juan Huang, Nadeem R Abu-Rustum, et al.
Gynecologic Oncology
|
August 17, 2010
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers
Mario M Leitao, Graham V Byrum, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller
Dennis S Chi, Joyce N Barlin, Pedro T Ramirez, et al.
Gynecologic Oncology
|
September 8, 2004
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Dennis S Chi, Corinna C Franklin, Douglas A Levine, et al.
Gynecologic Oncology
|
August 20, 2010
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors
Karin K Shih, Qin C Zhou, Carol Aghajanian, et al.
Retina (Philadelphia, Pa.)
|
March 9, 2023
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
Charles C Wykoff, Hidetaka Matsumoto, Mark R Barakat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity
D J Gallagher, J A Konner, K M Bell-McGuinn, et al.
JAMA Ophthalmology
|
November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map
Arshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
Page
of 41
Search research articles
Search
Showing results (311-320 of 402) with videos related to
Sort By:
Page
of 41
Gynecologic Oncology
|
January 11, 2011
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma
John P Diaz, Mary L Gemignani, Neeta Pandit-Taskar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 9, 2013
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications
Samith Sandadi, Edward J Tanner, Fady Khoury-Collado, et al.
Gynecologic Oncology
|
March 4, 2014
Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies
Elizabeth L Jewell, Juan Juan Huang, Nadeem R Abu-Rustum, et al.
Gynecologic Oncology
|
August 17, 2010
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers
Mario M Leitao, Graham V Byrum, Nadeem R Abu-Rustum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller
Dennis S Chi, Joyce N Barlin, Pedro T Ramirez, et al.
Gynecologic Oncology
|
September 8, 2004
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Dennis S Chi, Corinna C Franklin, Douglas A Levine, et al.
Gynecologic Oncology
|
August 20, 2010
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors
Karin K Shih, Qin C Zhou, Carol Aghajanian, et al.
Retina (Philadelphia, Pa.)
|
March 9, 2023
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
Charles C Wykoff, Hidetaka Matsumoto, Mark R Barakat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2010
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity
D J Gallagher, J A Konner, K M Bell-McGuinn, et al.
JAMA Ophthalmology
|
November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map
Arshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
Page
of 41